• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of different interventions on prognosis and quality of life in patients with atrial fibrillation.不同干预措施对心房颤动患者预后和生活质量的影响。
Ann Noninvasive Electrocardiol. 2023 Jan;28(1):e13031. doi: 10.1111/anec.13031. Epub 2022 Dec 19.
2
Long-term outcomes of left atrial appendage closure with or without concomitant pulmonary vein isolation:a propensity score matching analysis based on CLACBAC study.基于 CLACBAC 研究的倾向评分匹配分析:左心耳封堵术联合或不联合肺静脉隔离术的长期结局。
BMC Cardiovasc Disord. 2024 Feb 3;24(1):85. doi: 10.1186/s12872-024-03725-1.
3
One-stop hybrid procedure combining catheter ablation and left atrial appendage closure increases long-term risk for adverse events in patients with atrial fibrillation.一站式杂交手术(导管消融联合左心耳封堵术)增加了房颤患者长期不良事件的发生风险。
Pacing Clin Electrophysiol. 2020 Nov;43(11):1358-1365. doi: 10.1111/pace.14084. Epub 2020 Oct 10.
4
[Comparison of 5-year follow-up outcomes between"one-stop"procedure and long-term oral anticoagulants after radiofrequency catheter ablation in patients with atrial fibrillation].
Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Sep 24;51(9):951-957. doi: 10.3760/cma.j.cn112148-20230622-00368.
5
Determinants of postoperative left atrial structural reverse remodeling in patients undergoing combined catheter ablation of atrial fibrillation and left atrial appendage closure procedure.接受房颤导管消融联合左心耳封堵术患者术后左心房结构逆重构的决定因素。
J Cardiovasc Electrophysiol. 2019 Oct;30(10):1868-1876. doi: 10.1111/jce.14094. Epub 2019 Aug 7.
6
One-stop procedure of "atrial fibrillation radiofrequency ablation + left atrial appendage closure + coronary artery fistula embolization": A case report.一站式手术:“心房颤动射频消融+左心耳封堵+冠状动脉瘘栓塞”:一例报告。
Perfusion. 2023 Oct;38(7):1526-1529. doi: 10.1177/02676591221113646. Epub 2022 Jul 5.
7
One-stop procedure of "Atrial fibrillation radiofrequency ablation + left atrial appendage closure" guided by 3D printing technology: A case report.3D 打印技术引导下一站式“房颤射频消融+左心耳封堵”术:1 例报告。
Echocardiography. 2023 Aug;40(8):856-861. doi: 10.1111/echo.15572. Epub 2023 Jun 16.
8
Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis.残余分流可能增加非瓣膜性心房颤动患者接受导管消融联合经导管左心耳封堵治疗后不良事件的风险:一项荟萃分析。
BMC Cardiovasc Disord. 2019 Jun 10;19(1):138. doi: 10.1186/s12872-019-1123-2.
9
[Success rate of one-stop procedure for atrial fibrillation ablation and its impact on cardiac function: a propensity-matched study].[心房颤动消融一站式手术的成功率及其对心功能的影响:一项倾向匹配研究]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Oct 30;40(10):1415-1421. doi: 10.12122/j.issn.1673-4254.2020.10.06.
10
Outcome and safety of intracardiac echocardiography guided left atrial appendage closure within zero-fluoroscopy atrial fibrillation ablation procedures.心腔内超声引导下零射线房颤消融术中左心耳封堵术的疗效和安全性。
J Cardiovasc Electrophysiol. 2022 Apr;33(4):667-676. doi: 10.1111/jce.15370. Epub 2022 Jan 25.

引用本文的文献

1
Long-term outcomes of left atrial appendage closure techniques on stroke prevention of recurrent atrial fibrillation patients: epicardial excision versus percutaneous occlusion.左心耳闭合技术对复发性心房颤动患者预防中风的长期疗效:心外膜切除与经皮闭塞对比
Front Cardiovasc Med. 2025 Jun 4;12:1601303. doi: 10.3389/fcvm.2025.1601303. eCollection 2025.
2
Combined Catheter Ablation and Left Atrial Appendage Occlusion in Atrial Fibrillation: From Data to Clinical Reality.房颤的导管消融与左心耳封堵联合应用:从数据到临床实践
Cardiovasc Drugs Ther. 2025 Apr 16. doi: 10.1007/s10557-025-07685-2.
3
Left atrial appendage occlusion in atrial fibrillation: shaping the future of stroke prevention.心房颤动中的左心耳封堵:塑造卒中预防的未来。
Future Cardiol. 2025 May;21(6):391-404. doi: 10.1080/14796678.2025.2484964. Epub 2025 Mar 26.
4
Long-term outcomes of left atrial appendage closure with or without concomitant pulmonary vein isolation:a propensity score matching analysis based on CLACBAC study.基于 CLACBAC 研究的倾向评分匹配分析:左心耳封堵术联合或不联合肺静脉隔离术的长期结局。
BMC Cardiovasc Disord. 2024 Feb 3;24(1):85. doi: 10.1186/s12872-024-03725-1.

本文引用的文献

1
Long-term outcome of combined catheter ablation and left atrial appendage closure in atrial fibrillation patients.心房颤动患者联合导管消融与左心耳封堵的长期预后
Int J Cardiol. 2022 Dec 1;368:41-48. doi: 10.1016/j.ijcard.2022.08.007. Epub 2022 Aug 8.
2
Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.过去5年经导管左心耳封堵装置及直接口服抗凝药治疗心房颤动患者的最新结果:一项系统评价和荟萃分析
Cardiovasc Interv Ther. 2022 Oct;37(4):725-738. doi: 10.1007/s12928-022-00839-1. Epub 2022 Jan 30.
3
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial.年龄与导管消融与药物治疗房颤结局的相关性:CABANA 试验结果。
Circulation. 2022 Mar 15;145(11):796-804. doi: 10.1161/CIRCULATIONAHA.121.055297. Epub 2021 Dec 22.
4
Clinical benefit of left atrial appendage closure in octogenarians.八旬老人左心耳封堵术的临床获益
J Geriatr Cardiol. 2021 Nov 28;18(11):886-896. doi: 10.11909/j.issn.1671-5411.2021.11.003.
5
Current evidence on the safety and efficacy of combined atrial fibrillation ablation and left atrial appendage closure.目前关于房颤消融联合左心耳封堵安全性和有效性的证据。
Curr Opin Cardiol. 2022 Jan 1;37(1):74-79. doi: 10.1097/HCO.0000000000000913.
6
The feasibility and safety of "one-stop" left atrial appendage closure and percutaneous coronary intervention in atrial fibrillation patients with significant coronary artery disease (PCI-LAAC study).“一站式”左心耳封堵术与经皮冠状动脉介入治疗在合并严重冠状动脉疾病的房颤患者中的可行性与安全性(PCI-LAAC研究)
Am J Cardiovasc Dis. 2021 Oct 25;11(5):679-687. eCollection 2021.
7
Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.经皮左心耳封堵术治疗原发性止血障碍合并心房颤动患者。
J Interv Card Electrophysiol. 2022 Aug;64(2):497-509. doi: 10.1007/s10840-021-01073-0. Epub 2021 Nov 25.
8
Atrial appendage closure in patients with heart failure and atrial fibrillation: industry-independent single-centre study.心房颤动伴心力衰竭患者的左心耳封堵:独立于产业界的单中心研究。
ESC Heart Fail. 2022 Feb;9(1):648-655. doi: 10.1002/ehf2.13698. Epub 2021 Nov 15.
9
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.左心耳封堵术与非华法林口服抗凝药治疗心房颤动的 4 年结局。
J Am Coll Cardiol. 2022 Jan 4;79(1):1-14. doi: 10.1016/j.jacc.2021.10.023. Epub 2021 Nov 5.
10
Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation.左心耳封堵术:即使进行口服抗凝治疗,也能预防心源性栓塞事件的新策略。
Panminerva Med. 2023 Jun;65(2):227-233. doi: 10.23736/S0031-0808.21.04446-3. Epub 2021 Oct 19.

不同干预措施对心房颤动患者预后和生活质量的影响。

Effects of different interventions on prognosis and quality of life in patients with atrial fibrillation.

机构信息

Department of Cardiology, Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China.

出版信息

Ann Noninvasive Electrocardiol. 2023 Jan;28(1):e13031. doi: 10.1111/anec.13031. Epub 2022 Dec 19.

DOI:10.1111/anec.13031
PMID:36534033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9833365/
Abstract

OBJECTIVE

To compare the effects of different intervention measures on prognosis and quality of life in patients with atrial fibrillation, in order to provide clinical basis for diagnosis and treatment.

METHODS

A total of 160 patients who visited several hospitals including Shanghai Xinhua Hospital from June 2019 to June 2021 were selected. Among them, 40 cases were in the drug treatment group (DRUG group), 40 cases in the radiofrequency ablation group (Radiofrequency ablation, RFA group), and 40 cases in the catheter ablation combined with percutaneous left atrial appendage occlusion group (""one-stop"" procedure group) and 40 cases in the percutaneous left atrial appendage closure group (Left atrial appendage closure, LAAC group). The Minnesota quality of life score (MLHFQ), ejection fraction (LVEF), and left atrial anterior and posterior diameters (LAD) were compared between the groups at 1-year follow-up, and the differences in adverse events were compared between the groups.

RESULTS

(1) After a 1-year follow-up, overall comparison, the MLHFQ scores and the LVEF and the LAD among the four groups were statistically different (p < .01); (2) Multiple comparisons, ① the MLHFQ scores: The RFA group was the lowest, the "one-stop" operation group was lower than the DRUG group, the LAAC group was the highest (p < .01). ② LVEF: The RFA group was the highest, the "one-stop" procedure group was higher than the drug treatment group, the LAAC group was the lowest (p < .01). ③ LAD: the RFA group and the "one-stop" procedure group were smaller than the DRUG group, the DRUG group was smaller than the LAAC group (p < .01).(3) Compared with the baseline data after 1-year follow-up in each group, in the RFA group and in the "one-stop" procedure group, the MLHFQ scores was decreased, the LVEF was increased, and the LAD was decreased (p < .01); in the DRUG group: the difference was not statistically significant (p > .05); in the LAAC group, the MLHFQ scores was increased, the LVEF was decreased, and the LAD was increased (p < .01). (4) There were significant differences in the incidence of adverse events among the four groups (p < .01), the lowest in the RFA group and the highest in the LAAC group.

CONCLUSION

Compared with drug treatment, radiofrequency ablation and "one-stop" procedure group can improve the quality of life of patients with atrial fibrillation, improve cardiac function, and reduce the occurrence of adverse events. Percutaneous left atrial appendage occlusion affects patients' quality of life and improves cardiac function, and increases the incidence of adverse events.

摘要

目的

比较不同干预措施对心房颤动患者预后和生活质量的影响,为临床诊断和治疗提供依据。

方法

选取 2019 年 6 月至 2021 年 6 月在上海新华医院等多家医院就诊的 160 例患者为研究对象,其中药物治疗组(DRUG 组)40 例、射频消融组(Radiofrequency ablation,RFA 组)40 例、导管消融联合经皮左心耳封堵“一站式”手术组(“一站式”手术组)40 例、经皮左心耳封堵组(Left atrial appendage closure,LAAC 组)40 例。比较各组患者 1 年随访时的明尼苏达生活质量评分(Minnesota quality of life score,MLHFQ)、射血分数(left ventricular ejection fraction,LVEF)、左心房前后径(left atrial anterior and posterior diameters,LAD),比较各组不良事件的差异。

结果

(1)1 年随访时,各组间整体比较,MLHFQ 评分及 LVEF、LAD 比较差异均有统计学意义(p<0.01);(2)多重比较,①MLHFQ 评分:RFA 组最低,“一站式”手术组低于药物治疗组,LAAC 组最高(p<0.01)。②LVEF:RFA 组最高,“一站式”手术组高于药物治疗组,LAAC 组最低(p<0.01)。③LAD:RFA 组、“一站式”手术组小于药物治疗组,药物治疗组小于 LAAC 组(p<0.01)。(3)与各组患者 1 年随访时的自身基线数据比较,RFA 组和“一站式”手术组 MLHFQ 评分降低,LVEF 升高,LAD 降低(p<0.01);药物治疗组:差异无统计学意义(p>0.05);LAAC 组 MLHFQ 评分升高,LVEF 降低,LAD 升高(p<0.01)。(4)四组患者不良事件发生率比较差异有统计学意义(p<0.01),RFA 组发生率最低,LAAC 组发生率最高。

结论

与药物治疗相比,射频消融术和“一站式”手术组可改善心房颤动患者的生活质量,改善心功能,减少不良事件的发生。经皮左心耳封堵术影响患者生活质量,改善心功能,增加不良事件的发生。